Hyperlipidemia Risk Discussion

Hyperlipidemia is not simply an abnormal cholesterol result. The clinical problem is prolonged exposure to atherogenic lipoprotein particles, particularly LDL particles that contain apolipoprotein B. These particles can enter the arterial intima, undergo modification, recruit monocytes, and produce foam cells and enlarging plaque. Plaque rupture or erosion can then trigger thrombosis, myocardial infarction, ischemic stroke, or peripheral arterial events. The relevant exposure is cumulative. A mildly elevated LDL-C sustained for decades may produce more arterial injury than one isolated high result discovered late in life. Conversely, a single lipid value does not determine risk by itself. The NP must connect the lipid pattern with established atherosclerotic disease, diabetes, kidney disease, blood pressure, smoking, family history, age, and the patient's treatment goals. A useful risk discussion therefore has three tasks: identify whether disease is already present, determine whether the lipid pattern requires treatment independent of a calculated score, and help the patient decide how to reduce future events. The aim is not to make a laboratory number look normal; it is to lower the patient's probability of a preventable cardiovascular event...